3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
CNS
1
Conditions
Neoplasms
3
Venous Thrombosis
2
Venous Thromboembolism
2
Thrombosis
2
Pulmonary Embolism
2
Urinary Tract Infections
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Thromboembolism
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Retinitis
1
Renal Insufficiency, Chronic
1
Pulmonary Arterial Hypertension
1
Prostatic Neoplasms
1
Pneumonia
1
Pancreatic Neoplasms
1
Pain
1
Neutropenia
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Migraine Disorders
1
Menorrhagia
1
Meningitis, Bacterial
1
Meningitis
1
Intraabdominal Infections
1
Interventions
Rocuronium
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
ziprasidone
1
venetoclax
1
saponin QA-21V1
1
perflutren
1
finerenone
1
empagliflozin
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Thalidomide
1
Surveys and Questionnaires
1
Stem Cell Transplantation
1
Spironolactone
1
Specimen Handling
1
Simethicone
1
Sevelamer
1
Resistance Training
1
Quillaja Saponins
1
Protein Subunit Vaccines
1
Polymorphism, Genetic
1
Piperacillin, Tazobactam Drug Combination
1
Phlebotomy
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Renal Insufficiency, Chronic
×
Warfarin
×
Clear all
NCT01431326
2023-09-06
PTN_POPS
Duke University
Completed
3,520 enrolled